Current Management Decisions in Mild Cognitive Impairment

• Autores: Benjamin A. Bensadon, Germaine Odenheimer
• Localización: Clinics in geriatric medicine, ISSN 0749-0690, Vol. 29, Nº. 4, 2013, págs. 847-871
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Efforts toward early detection of Alzheimer disease (AD) have focused on refinement and identification of diagnostic markers, with the goal of preventing or delaying disease progression. Mild cognitive impairment (MCI) has emerged as a potential precursor to dementia. Though not without controversy, MCI has been associated with an increased risk for conversion to AD. In this article, with emphasis on meta-analyses, randomized controlled trials, and extant literature reviews, considerations and recommendations for optimal clinical management of MCI are offered. Given the substantial heterogeneity of this patient population and inconsistent research methodologies, the need for informed, clinical judgment is critical.